- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/073 - Embryonic cells or tissuesFoetal cells or tissues
Patent holdings for IPC class C12N 5/073
Total number of patents in this class: 1539
10-year publication summary
|
117
|
107
|
123
|
133
|
132
|
120
|
117
|
101
|
103
|
85
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Osiris Therapeutics, Inc. | 107 |
32 |
| Celeniv Pte. Ltd. | 83 |
24 |
| ViaCyte, Inc. | 179 |
20 |
| Accelerated Biosciences Corp. | 34 |
18 |
| The Regents of the University of California | 20868 |
16 |
| California Institute of Technology | 4038 |
15 |
| Pluri Biotech Ltd. | 56 |
15 |
| Cambridge Enterprise Limited | 1246 |
14 |
| Kyoto University | 2931 |
14 |
| Inguran, LLC | 229 |
13 |
| Pluristem Ltd. | 37 |
12 |
| Anthrogenesis Corporation | 64 |
11 |
| President and Fellows of Harvard College | 6111 |
10 |
| MiMedx Group, Inc. | 211 |
9 |
| University Health Network | 1068 |
9 |
| CellResearch Corporation Pte Ltd. | 59 |
9 |
| Centre National de La Recherche Scientifique | 11092 |
8 |
| Kaneka Corporation | 4768 |
8 |
| Amorphical Ltd. | 70 |
8 |
| China Agricultural University | 359 |
8 |
| Other owners | 1266 |